# Adaptive Capital Partners

> Adaptive Capital Partners is a VC fund in Singapore backing Health Care and Fitness. See 7 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Singapore, Singapore
- Total investments: 7
- Last investment: Jul 2025
- Lead investor: 29%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/adaptive-capital-partners/

Adaptive Capital Partners is a early-stage technology focused venture capital firm.

## Round sizes

| Stage | Round size |
| --- | --- |
| Series A | $3.5M–$17M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 4 | 57% |
| Fitness | 1 | 14% |
| Medical | 1 | 14% |
| mHealth | 1 | 14% |
| Internet | 1 | 14% |

19 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 4 | 57% |
| Funding Round | 1 | 14% |
| Venture - Series Unknown | 1 | 14% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Singapore | 3 | 43% |
| Malaysia | 1 | 14% |
| United States | 1 | 14% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Respiree | They offer platforms that are able to report clinical deterioration and provide recommended interventions with post-monitoring.They work in the health care industry, just like you. We take the time to get to know you, and we always keep your best interests in mind when adding and adjusting products in our catalog. | $11.6M | Series A | Jul 23, 2025 |  |
| Lapasar.com | Lapasar.com is a B2B marketplace, giving corporate buyers access to suppliers across Malaysia - via the marketplace & via RFQ tools. To adhere to and strengthen corporate governance, the marketplace comes with integrated procurement tools in the backend. | $6.5M | Venture - Series Unknown | Feb 16, 2024 |  |
| Biorithm | Biorithm is a company that creates obstetrics remote monitoring platforms and point-of-care devices for pregnant and postnatal patients. The company combines proprietary data analytics software and medical-grade wearables to monitor a wide range of pregnancy vital data such as fetal heart rate, uterine contractions, and maternal heart rate,allowing clinicians to gain new insights into the health of the mother and baby while also providing expecting mothers with better access to healthcare, convenience, and more information about their pregnancy to identify early signs of complications. | $3.5M | Series A | Dec 18, 2023 |  |
| Biorithm | Biorithm is a company that creates obstetrics remote monitoring platforms and point-of-care devices for pregnant and postnatal patients. The company combines proprietary data analytics software and medical-grade wearables to monitor a wide range of pregnancy vital data such as fetal heart rate, uterine contractions, and maternal heart rate,allowing clinicians to gain new insights into the health of the mother and baby while also providing expecting mothers with better access to healthcare, convenience, and more information about their pregnancy to identify early signs of complications. | $3.5M | Series A | Dec 18, 2023 |  |
| AOA | AOA Dx is a biotechnology company with a team of entrepreneurs that brings innovative, impactful, and cost-effective medical technologies from research and development into the hands of providers and patients. The company is driven by a mission to bring to market the first accurate early-stage non-invasive ovarian cancer diagnostic test that willimprove clinical practice and help reduce patient mortality. | $17M |  | Oct 11, 2023 |  |
| AOA | AOA Dx is a biotechnology company with a team of entrepreneurs that brings innovative, impactful, and cost-effective medical technologies from research and development into the hands of providers and patients. The company is driven by a mission to bring to market the first accurate early-stage non-invasive ovarian cancer diagnostic test that willimprove clinical practice and help reduce patient mortality. | $17M | Series A | Oct 11, 2023 |  |
| Aktivo Labs | Founded in 2017 by medical doctors and data scientists, Aktivolabs is on a mission to prevent chronic diseases globally. Our real-time digital health platform empowers enterprises & governments to build scalable, evidence-based health & well-being solutions. Clients include the world's largest Insurance companies, health super-apps,large employers, consumer products companies, and enterprise-level corporations. Aktivolabs investors include Mitsui & Co., SEEDS Capital (the investment arm of Enterprise Singapore), and Adaptive Capital Partners. The company is headquartered in Singapore with offices in New York, Cambridge UK, and India. To learn more, please visit the website www.aktivolabs.com. | $10M | Series A | Dec 14, 2022 |  |

7 of 7 investments shown.

## Co-investors
- [Seeds Capital](https://shizune.co/investors/profile/seeds-capital) — VC Fund, 4 deals together
- [Cancer Fund](https://shizune.co/investors/profile/cancer-fund) — VC Fund, 2 deals together
- [FemHealth Ventures](https://shizune.co/investors/profile/femhealth-ventures) — VC Fund, 2 deals together
- [Good Growth Capital](https://shizune.co/investors/profile/good-growth-capital) — VC Fund, 2 deals together
- [Gore Range Capital](https://shizune.co/investors/profile/gorerange-capital) — VC Fund, 2 deals together
- [LabCorp Venture Fund](https://shizune.co/investors/profile/labcorp-venture-fund) — VC Fund, 2 deals together

## Similar investors

### Similar industry
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Seeds Capital](https://shizune.co/investors/profile/seeds-capital) — VC Fund
- [Wavemaker Ventures](https://shizune.co/investors/profile/wavemaker-partners) — VC Fund

## Featured in investor lists
- [Health Care VC Funds in Singapore](https://shizune.co/investors/health-care-vc-funds-singapore)
- [Health Care Investors in Singapore](https://shizune.co/investors/health-care-investors-singapore)
- [Medical Investors in Singapore](https://shizune.co/investors/medical-investors-singapore)
- [Medical VC Funds in Singapore](https://shizune.co/investors/medical-vc-funds-singapore)
- [Medical Device Investors in Singapore](https://shizune.co/investors/medical-device-investors-singapore)
- [Medical Device VC Funds in Singapore](https://shizune.co/investors/medical-device-vc-funds-singapore)

## FAQ

### What does Adaptive Capital Partners invest in?

Adaptive Capital Partners invests primarily in Health Care, Fitness and Medical startups, most often at Series A and Funding Round stage. Most of the 7 investments tracked by Shizune back companies in Singapore. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Adaptive Capital Partners's check size?

Adaptive Capital Partners typically joins rounds of $3.5M–$17M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Adaptive Capital Partners participates in.

### When did Adaptive Capital Partners last invest?

The most recent investment recorded for Adaptive Capital Partners closed in Jul 2025. Shizune tracks 7 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co